Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
MRI-Guided Radiotherapy Boost in Head and Neck Cancer
NCT06880289Phase 2Active, not recruiting
- Sponsor
- IRCCS Regina Elena National Cancer Institute
- Start
- Sep 2020
- Primary completion
- Jul 2024
- Countries
- 1
01
Overview
Phase 2, randomised, open-label trial in squamous cell carcinoma of the head and neck (HNSCC) (2 arms), sponsored by IRCCS Regina Elena National Cancer Institute. Primary endpoint: Complete response at 2 years. Started Sep 2020; status: active, not recruiting.
02
Conditions
squamous cell carcinoma of the head and neck (HNSCC)
Beyond the preview
Go deeper on NCT06880289.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06880289.